Surgical Menopause: When Your Hormones Disappear Overnight

I need to be direct about this, because I've read the studies and I'm frustrated on your behalf.

The Honigberg et al. study, published in JAMA in 2019, drew from the UK Biobank — 144,260 postmenopausal women, followed for a median of 7 years. I want to be direct about this.. Among women with surgical premature menopause (oophorectomy before age 40), the hazard ratio for composite cardiovascular disease was 1.87, adjusted for conventional risk factors and menopausal hormone therapy use. The incidence rate was 11.27 per 1,000 woman-years, compared to 5.70 per 1,000 woman-years in women with no premature menopause. That's nearly double.

For natural premature menopause (before 40, without surgery), the HR was 1.36. Still elevated, but notably lower than surgical. The difference tells you something important: it's not just about being young when estrogen declines. It's about the speed and completeness of the decline.

The Rocca group at Mayo Clinic published one of the most important findings in this field. In their cohort study of women who underwent bilateral oophorectomy before menopause, those who received estrogen replacement through at least age 50 had a cardiovascular mortality HR of 0.65 — actually lower than the referent population. Women who did NOT receive estrogen? HR 1.84. The gap between 0.65 and 1.84 isn't a statistical curiosity. It's the difference between a treatment that protects and an omission that harms.

So here's what makes me angry: this data has been published, replicated, and endorsed by every major menopause society in the world. NAMS, IMS, the British Menopause Society, the Endocrine Society — all recommend HRT for women with premature surgical menopause until at least the average age of natural menopause (51). And yet. The posts in our database describe women waiting 5, 10, 18 years post-oophorectomy before being prescribed estrogen. One woman described developing severe osteoporosis and two hip fractures before a physician finally relented. Another described five years of refused HRT after endometrial cancer, during which she developed high blood pressure, high cholesterol, hair loss, and clinical depression.

The WHI study was published in 2002. It studied women with an average age of 63 — decades past menopause. It has nothing to do with a 36-year-old who lost her ovaries to endometriosis. Applying WHI data to surgical menopause in premenopausal women is like applying geriatric blood pressure guidelines to a teenager. The numbers don't transfer. But the fear does. This is a core aspect of menopause surgical that deserves clinical attention.